Circulation Research. 2000;86:111-113
(Circulation Research. 2000;86:111.)
© 2000 American Heart Association, Inc.
Under New Management
A Six-Month Progress Report on Circulation Research
Eduardo Marbán,
Roberto Bolli,
Gerda Breitwieser,
Rudi Busse,
Hal Dietz,
Masao Endoh,
Toren Finkel,
David Kass,
Charles Lowenstein,
Marlene Rabinovitch,
Gordon Tomaselli
From the Editor in Chief and Associate Editors,
Circulation Research.
Correspondence to Eduardo Marbán, MD, PhD, 2700 Lighthouse Point East, Suite 230, Baltimore, MD 21224.
Key Words: research commentary vascular biology acceptance rate triage process
 |
Introduction
|
|---|
The editorship of
Circulation Research
was transferred to us
on July 1, 1999. The new editors would like to
review the directions
that the journal has taken in this time, now that
6 months of
data are available. Such an evaluation is particularly
timely
given that the transition was not merely an editorial one: we
deliberately
seized the opportunity to implement fundamental changes in
the
process, notably:
An editorial commitment to decisive action and clear
communication
All-electronic manuscript management from receipt in the editorial
office to transmission to the publisher
New efforts to maximize information content on the printed page,
including the use of online supplements for extended methods and
miscellaneous supporting information
Institution of two new electronic manuscript formats: UltraRapid
Communications, in which high-priority manuscripts are reviewed very
quickly and published online within 1 month of acceptance, and
Research Commentaries, peer-reviewed technical comments on work that
has appeared in Circulation Research
Adoption of a manuscript triage process whereby noncompetitive or
inappropriate manuscripts (comprising about 10% of overall
submissions) are identified early in the process, enabling rapid
feedback to the authors
Meanwhile, the underlying editorial philosophy has been to do what
we can to make Circulation Research the preferred venue for
fundamental cardiovascular discovery and translational
research. As a corollary, we have consciously sought to maintain
balance among the important modern disciplines, including a commitment
to nurture the well-established prominence of the journal in vascular
biology.
The data indicate that we have made significant progress toward our
goals. Figure 1A
shows that the overall
acceptance rate for original articles in Circulation
Research, in the first 6 months of our editorship, equaled 22%.
This acceptance rate reflects only final decisions; less than
3% of manuscripts are accepted at the time of first decision. The vast
majority of the manuscripts that we eventually publish are initially
identified as worthy of reconsideration after revision; few manuscripts
in which revision is discouraged end up being accepted. The low
acceptance rate reflects the reality of limited page budgets as
well as a conscious effort by the editors to select manuscripts that
are not only outstanding scientifically but also that have broad appeal
to the diverse readership of the journal.

View larger version (35K):
[in this window]
[in a new window]
|
Figure 1. A, Comparative acceptance rates for
manuscripts in the vascular biology (22.2%) and nonvascular biology
(21.6%) fields. The average acceptance rate for the journal is
equal to 22%. B, Outline of the submission rates for manuscripts,
again in vascular biology (48.2%) and nonvascular biology (51.8%)
fields.
|
|
Fostering that diversity means maintaining a judicious balance between
studies that address problems of the vasculature versus those of the
heart itself. Under its previous editorship, Circulation
Research became a balanced vascular-cardiac journal. To determine
whether this remains true in the new regime, we have examined
separately the acceptance rates and submission rates for the
two disciplines. When decisions are broken down into vascular biology
manuscripts versus those in other disciplines, the acceptance
rates are comparable, with vascular biology coming out slightly higher
(Figure 1A
). Meanwhile, almost half of the original manuscripts
that have been received by the Baltimore office have been vascular
biology studies (Figure 1B
). In summary, the data reveal that
vascular biology continues to thrive at Circulation
Research.
Our commitment to decisive action, taking full advantage of electronic
opportunities to enhance efficiency, has yielded dramatic results. We
are particularly proud of our record in accelerating the manuscript
review process. The average time from submission to first decision now
equals a scant 3 weeks; Figure 2
shows
the breakdown among manuscript categories, which is notable for brevity
in all subsets but especially so for UltraRapid Communications. While
partly attributable to the efficiency of electronic communication, two
new editorial measures have helped to decrease the times to first
decision even more. First, the editors now read manuscripts upon
submission in an effort to identify those that are either inappropriate
for our journal or clearly noncompetitive. We often seek the advice of
one or more external reviewers, generally members of the Editorial
Board, in making this triage decision. Manuscripts identified early on
as noncompetitive or inappropriate are rejected without full review,
generally within 1 week of submission. We currently reject 10% of
submissions in this manner; given our acceptance rate of only
22%, the editors may decide to increase this triage fraction over the
coming months. Second, the editors now routinely read each review soon
after it has been submitted. This departure from the usual practice of
waiting until the manuscript file is "complete" enables us to
identify manuscripts of low (or high) priority early in the review
process. Such manuscripts are then reexamined by the editors; if
appropriate, the remaining reviewers are given a final opportunity to
respond, and an early decision is rendered. In either the triage or the
early-decision process, at least two individuals (two editors and
usually one or more external reviewers) see the manuscript and
contribute to the final decision. These measures not only enable rapid
feedback to authors but also provide some relief for our referees from
their reviewing burdens.

View larger version (42K):
[in this window]
[in a new window]
|
Figure 2. Average time to first decision for the overall
journal is 3 weeks (21 calendar days). For individual manuscript
categories, time to first decision is 3.8 weeks for original
contributions (n=451 manuscripts), 3.4 weeks for Brief Communications
(n=38 manuscripts), and 1.8 weeks for UltraRapid Communications (n=13
manuscripts).
|
|
These advances have been achieved despite a substantial increase in the
pace of submissions to the journal since the transition. Figure 3
plots the number of submitted
manuscripts over the last 13 years. The bar for 1999 shows continued
growth in overall submissions over previous years. The additional
chronological breakdown of that bar, in which the 6-month Baltimore
volume is shown on top, reveals a 26% increase after July 1, 1999. At
the current pace, we expect to handle more than 1500 new manuscripts in
the year 2000.

View larger version (36K):
[in this window]
[in a new window]
|
Figure 3. Number of manuscripts received chronologically has
been tracked over 13 years, from 1987 to 1999. For the last 6-month
period under the previous editorship (first half of 1999), 547
manuscripts were received in the Pittsburgh editorial office. For the
first 6 months of our editorship (second half of 1999), 745 manuscripts
were received in the Baltimore editorial office.
|
|
The two new categories of online-only articles deserve some comment. We
now have enough experience with UltraRapid Communications to be
confident that this new format is here to stay. UltraRapids now account
for about 1 of 20 submissions, a popularity that reflects the ease of
worldwide Internet access and the growing acceptance of
online-only publication. The submission rate speaks to authors
preference; a complementary measure of popularity is the "hit
frequency," which identifies readers preferences. The data here
demonstrate superior levels of interest for these high-priority
studies. On average, the first several UltraRapids attracted more than
400 hits each, including more than 200 full-text downloads, within the
first 3 months after publication. Several UltraRapids have been cited
multiple times in other peer-reviewed articles, as well as in the lay
press. By any measure, this category is off to a quick and successful
start. The second new online category, Research Commentaries, debuts in
this issue.1 2 These follow the general format of focused
technical comments on work that has previously appeared in our journal.
Research Commentaries are peer- reviewed; if deemed to be of sufficient
interest to merit publication, the authors of the original study are
then given a chance to respond. The response is also peer-reviewed.
Publication follows the UltraRapid process: abstracts for the Research
Commentary and the Response appear in the printed issue, with the
e-citation whereby the articles can be referenced.
Finally, the editors acknowledge that this progress would have been
impossible without the enthusiastic cooperation of our reviewers. Their
buy-in to electronic receipt of manuscript files and to Web-based
review submission has been nothing short of extraordinary. This
attitude is remarkable given the learning curve associated with any
effort to reinvent the way things are done. We have been acutely aware
of the limitations of our nascent Web-based manuscript management
system, including glitches in our homegrown software and occasional
lapses in server availability. We are very grateful to our referees for
their perseverance and for their crucial feedback role in our
conversion to an Internet-based process. Having pioneered the process
for the American Heart Association (AHA) journals, we are now relieved
to announce our editorial offices liberation from the
responsibilities of software development and server
maintenance. We have recently transferred the systems
operations and future development to Medical Support Systems (MSS) in
Cambridge, Massachusetts. Many of you will recognize MSS as the company
that spearheaded the electronic abstract submission and review process
for the AHA. The transfer of our system to MSS represents our
commitment, and that of the AHA, to our new way of doing business.
Reviewers and authors can now rest assured that an experienced
commercial venture will continue upgrading the software and will
respond to any user concerns that may arise. You may contact MSS at
mss@dbpub.com and, as always, you may reach us at
circulation.research@heart.org.
 |
References
|
|---|
-
Roth BJ. Influence of a perfusing bath on the
foot of the cardiac action potential. Circ Res. 2000;86:e19e22.
-
Spach MS, Barr RC. Effects of cardiac microstructure
on propagating electrical waveforms. Circ Res. 2000;86:e23e28.